MicroRNA-26b regulates cancer proliferation migration and cell cycle transition by suppressing TRAF5 in esophageal squamous cell carcinoma

American Journal of Translational Research

Volumn 8, Issue 5, 2016, Pages 1957-1970

  Chen, Zhuo ^a   Zhao, Liang ^a   Zhao, Feng ^a   Yang, Guanghai ^a   Wang, Jianjun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Esophageal squamous carcinoma; Migration; miR 26a; miR 26b; Proliferation; TRAF5

Indexed keywords

MICRORNA; MICRORNA 26A; MICRORNA 26B; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ASSAY; CELL CYCLE CHECKPOINT; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84971668243     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Napier KJ, Scheerer M and Misra S. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol 2014; 6: 112-120.
2. Siegel RL, Miller KD and Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5-29.
3. Herszenyi L and Tulassay Z. Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 2010; 14: 249-258.
4. Pennathur A, Gibson MK, Jobe BA and Luketich JD. Oesophageal carcinoma. Lancet 2013; 381: 400-412.
5. Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005; 15: 563-568.
6. Huang J, Zhang S., Gao YM, Liu YF, Liu YB, Zhao ZG and Yang K. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets. Cell Prolif 2014; 47: 277-286.
7. Sakai NS, Samia-Aly E, Barbera M and Fitzgerald RC. A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Semin Cancer Biol 2013; 23: 512-521.
8. Mayne GC, Hussey DJ and Watson DI. MicroR-NAs and esophageal cancer--implications for pathogenesis and therapy. Curr Pharm Des 2013; 19: 1211-1226.
9. Zhang YF, Zhang AR, Zhang BC, Rao ZG, Gao JF, Lv MH, Wu YY, Wang SM, Wang RQ and Fang DC. MiR-26a regulates cell cycle and anoikis of human esophageal adenocarcinoma cells through Rb1-E2F1 signaling pathway. Mol Biol Rep 2013; 40: 1711-1720.
10. Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM and Aggarwal BB. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene 2007; 26: 1385-1397.
11. Ha H, Han D and Choi Y. TRAF-mediated TNFR-family signaling. Curr Protoc Immunol 2009; Chapter 11: Unit11 19D.
12. Napetschnig J and Wu H. Molecular basis of NF-kappaB signaling. Annu Rev Biophys 2013; 42: 443-468.
13. Tao T, Cheng C, Ji Y, Xu G, Zhang J, Zhang L and Shen A. Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-kappaB activation. Mol Biol Cell 2012; 23: 2635-2644.
14. Liu P, Gao Y, Huan J, Ge X, Tang Y, Shen W, Tian Y, Shen W, Zou S, Zhou J and Zhang S. Upregulation of PAX2 promotes the metastasis of esophageal cancer through interleukin-5. Cell Physiol Biochem 2015; 35: 740-754.
15. Andl CD, Mizushima T, Nakagawa H, Oyama K, Harada H, Chruma K, Herlyn M and Rustgi AK. Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J Biol Chem 2003; 278: 1824-1830.
16. Fleige S, Walf V, Huch S, Prgomet C, Sehm J and Pfaffl MW. Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechnol Lett 2006; 28: 1601-1613.
17. Liang CC, Park AY and Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007; 2: 329-333.
18. Wong CF and Tellam RL. MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis. J Biol Chem 2008; 283: 9836-9843.
19. Alajez NM, Shi W, Hui AB, Bruce J, Lenarduzzi M, Ito E, Yue S, O’Sullivan B and Liu FF. Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death Dis 2010; 1: e85.